Sex-specific cardiovascular drug dosages needed to reduce adverse reactions in women

June 15, 2017

Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper from the European Society of Cardiology published today in the June issue of European Heart Journal - Cardiovascular Pharmacotherapy.

"Cardiovascular diseases kill a greater proportion of than men in Europe, and they kill twice as many women as all cancers combined," said lead author Dr Juan Tamargo, director of the Cardiovascular Pharmacology Research Group, Universidad Complutense, Madrid, Spain.

"Cardiovascular recommendations are based on in middle-aged men," continued Dr Tamargo. "Women have more adverse reactions from current dosages and may stop taking preventive medication, leaving them unprotected despite their higher risk."

The position paper outlines the differences between women and men with respect to cardiovascular medications and gives recommendations on how to improve treatment in women.

Key differences between women and men with respect to cardiovascular diseases and drugs:

  • Women are at greater risk of cardiovascular disease than men because they live longer.
  • Cardiovascular drug recommendations are based on clinical trials in middle-aged men.
  • Adverse drug reactions are more severe and more common in women than men.
  • Women less often receive preventive treatments and are treated less aggressively than men.
  • Women and men absorb, distribute, metabolise, and excrete drugs differently.

Dr Tamargo said: "Male physicians less often prescribe recommended medications for female patients. Some doctors think is not a real issue for women because they are protected by sex hormones, forgetting that this disappears with age and women live longer than men."

Women have a 1.5 to 1.7-fold greater incidence of adverse reactions to cardiovascular drugs and they tend to be more severe than in men, more often needing hospital admission. For example, women have a higher risk of drug-induced torsades de pointes (an abnormal heart rhythm than can lead to sudden cardiac death) and severe bleeding. Statin-induced myopathy is more common in older women with low body weight.

"Women have more adverse reactions because for many drugs the same dose is recommended for everyone irrespective of body weight," said Dr Tamargo. "This can lead to higher plasma levels and overdoses in women."

There are sex-related differences in the pharmacokinetics (the way a drug is absorbed, distributed, biotransformed and excreted) of some widely used cardiovascular drugs. For example, the bioavailability and plasma levels of aspirin are higher in women than men, possibly due to lower activity of the enzyme aspirin esterase, and greater distribution and lower clearance of aspirin. These differences vanish with oral contraceptives and during pregnancy.

Dr Tamargo said: "Sex-related recommendations for drug dosages are not included on labels, even for drugs with a greater than 40% difference in pharmacokinetics between men and women."

Sex-related differences also occur in cardiovascular drug pharmacodynamics (the relationship between drug effect and drug concentration at the site of action). For example, aspirin has a higher protective effect against stroke in women and against heart attack in men. Aspirin is more active in male platelets, and aspirin resistance is more frequent in women.

The paper recommends:

  • Develop and implement sex-specific guidelines for cardiovascular drugs.
  • Include sex-specific dosages on cardiovascular drug labels.
  • Enrol women in clinical trials of cardiovascular drugs.
  • Educate doctors about sex differences in the pharmacokinetics and pharmacodynamics of cardiovascular drugs.

Dr Tamargo concluded: "The most effective way to minimise adverse drug reactions in women is to develop and implement sex-specific guidelines for ."

Explore further: Breast cancer risk reduced in women with diabetes who take low-dose aspirin

More information: J. Tamargo et al, Gender differences in the effects of cardiovascular drugs, European Heart Journal - Cardiovascular Pharmacotherapy (2017). DOI: 10.1093/ehjcvp/pvw042

Related Stories

Breast cancer risk reduced in women with diabetes who take low-dose aspirin

June 8, 2017
A new study of nearly 149,000 women with diabetes over 14 years showed an overall 18% reduced breast cancer risk for women who used low-dose aspirin compared to those who did not. The study design and results are published ...

Why don't more women take a daily aspirin to prevent heart disease?

April 4, 2012
Heart disease is the leading cause of death among women, and evidence-based national guidelines promote the use of daily aspirin for women at increased risk for cardiovascular disease. However, less than half of the women ...

Cons of regular low dose aspirin to stave off serious illness in women outweigh pros

December 4, 2014
The pros of giving healthy women regular low dose aspirin to stave off serious illness, such as cancer and heart disease, are outweighed by the cons, suggests a large study published online in the journal Heart.

Preterm delivery linked to greater risk of cardiovascular disease later in life

February 2, 2017
Previous studies have shown preterm delivery to be associated with an increased risk of cardiovascular disease, but it is unknown whether this risk remains after adjusting for a woman's pre-pregnancy lifestyle and risk factors ...

Recommended for you

New molecule may hold the key to triggering the regeneration and repair of damaged heart cells

August 21, 2017
New research has discovered a potential means to trigger damaged heart cells to self-heal. The discovery could lead to groundbreaking forms of treatment for heart diseases. For the first time, researchers have identified ...

Researchers investigate the potential of spider silk protein for engineering artificial heart

August 18, 2017
Ever more people are suffering from cardiac insufficiency, despite significant advances in preventing and minimising damage to the heart. The main cause of reduced cardiac functionality lies in the irreversible loss of cardiac ...

Lasers used to detect risk of heart attack and stroke

August 18, 2017
Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light to identify high-risk arterial plaques, according to research carried out at WMG, University of ...

Cholesterol crystals are sure sign a heart attack may loom

August 17, 2017
A new Michigan State University study on 240 emergency room patients shows just how much of a role a person's cholesterol plays, when in a crystallized state, during a heart attack.

How Gata4 helps mend a broken heart

August 15, 2017
During a heart attack, blood stops flowing into the heart; starved for oxygen, part of the heart muscle dies. The heart muscle does not regenerate; instead it replaces dead tissue with scars made of cells called fibroblasts ...

Injectable tissue patch could help repair damaged organs

August 14, 2017
A team of U of T Engineering researchers is mending broken hearts with an expanding tissue bandage a little smaller than a postage stamp.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.